Get notified of page updates
Enroll in Research > Research Search & Enroll Tool > Studying a Combination of Three Drugs to Treat Previously Untreated Metastatic Colorectal Cancer with Certain Tumor Markers
Glossary on
off
Printer Friendly Page Studying a Combination of Three Drugs to Treat Previously Untreated Metastatic Colorectal Cancer with Certain Tumor Markers

Studying a Combination of Three Drugs to Treat Previously Untreated Metastatic Colorectal Cancer with Certain Tumor Markers

Clinicaltrials.gov identifier:
NCT05217446


Study for metastatic colorectal cancer that has not yet been treated


Studying a Combination of Three Drugs to Treat Previously Untreated Metastatic Colorectal Cancer which Is MSI-High and Has a BRAF V600E Mutation

About the Study

This study is no longer enrolling people.

This study is being done to learn about the effects of using three study medicines together as treatment for colorectal cancer that has been previously untreated.

 

 

This Study is Open To:

This study is no longer enrolling people.

 

This Study is Not Open To:

This study is no longer enrolling people.